Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Collegium Pharmaceutical, Inc. (COLL) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.16B, a trailing price-to-earnings ratio of 4.6 and a free-cash-flow yield of 23.1%. Over the most recent reported fiscal year, revenue grew 23.6% and free cash flow per share grew 64.0%.